Malignant Transformation of Myomas: Myth or Reality?
- 1 March 2006
- journal article
- Published by Elsevier in Obstetrics and Gynecology Clinics of North America
- Vol. 33 (1) , 183-198
- https://doi.org/10.1016/j.ogc.2005.12.003
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group studyGynecologic Oncology, 2005
- Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcomaInternational Journal of Gynecologic Cancer, 2005
- Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcomaCancer, 2004
- Trimetrexate in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus: A Phase II Study of the Gynecologic Oncology GroupGynecologic Oncology, 2002
- Frequent Occurrence of Loss of Heterozygosity among Tumor Suppressor Genes in Uterine LeiomyosarcomaGynecologic Oncology, 1999
- Management of Uterine Leiomyosarcoma in AustraliaAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1999
- Uterine sarcomas in Norway 1956–1992: Incidence, survival and mortalityEuropean Journal Of Cancer, 1997
- Phase II Trial of Etoposide in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group StudyGynecologic Oncology, 1996
- Uterine Leiomyosarcoma and Endometrial Stromal Sarcoma: Lymph Node Metastases and Sites of RecurrenceGynecologic Oncology, 1993
- The Fruits of ConservatismBJOG: An International Journal of Obstetrics and Gynaecology, 1937